ALONGI, FILIPPO
 Distribuzione geografica
Continente #
NA - Nord America 20.586
EU - Europa 8.800
AS - Asia 8.700
SA - Sud America 2.259
Continente sconosciuto - Info sul continente non disponibili 509
AF - Africa 190
OC - Oceania 15
Totale 41.059
Nazione #
US - Stati Uniti d'America 20.094
SG - Singapore 3.106
CN - Cina 2.307
DE - Germania 2.032
BR - Brasile 1.858
PL - Polonia 1.475
UA - Ucraina 1.361
HK - Hong Kong 1.286
RU - Federazione Russa 924
GB - Regno Unito 860
IT - Italia 745
VN - Vietnam 684
FR - Francia 391
TR - Turchia 377
IE - Irlanda 336
BD - Bangladesh 293
FI - Finlandia 284
CA - Canada 243
IN - India 154
AR - Argentina 134
SE - Svezia 122
MX - Messico 85
ID - Indonesia 83
IQ - Iraq 72
EC - Ecuador 68
CO - Colombia 62
ZA - Sudafrica 52
AT - Austria 44
SA - Arabia Saudita 42
PK - Pakistan 40
ES - Italia 39
NL - Olanda 38
VE - Venezuela 37
CR - Costa Rica 36
JP - Giappone 35
BE - Belgio 33
JM - Giamaica 32
MA - Marocco 32
KE - Kenya 24
UZ - Uzbekistan 24
PY - Paraguay 23
PE - Perù 22
TT - Trinidad e Tobago 22
CL - Cile 21
EG - Egitto 18
IL - Israele 17
BO - Bolivia 16
CZ - Repubblica Ceca 16
JO - Giordania 16
TN - Tunisia 16
EU - Europa 15
AU - Australia 14
MY - Malesia 14
PH - Filippine 13
UY - Uruguay 13
GR - Grecia 12
NP - Nepal 12
SV - El Salvador 12
AE - Emirati Arabi Uniti 11
CH - Svizzera 11
GT - Guatemala 11
HN - Honduras 11
KZ - Kazakistan 11
LB - Libano 11
LT - Lituania 11
TW - Taiwan 11
AZ - Azerbaigian 10
DZ - Algeria 10
OM - Oman 10
ET - Etiopia 9
BH - Bahrain 8
DO - Repubblica Dominicana 8
EE - Estonia 8
PT - Portogallo 8
AL - Albania 7
KG - Kirghizistan 7
NG - Nigeria 7
NI - Nicaragua 7
IR - Iran 6
BG - Bulgaria 5
CI - Costa d'Avorio 5
DK - Danimarca 5
GP - Guadalupe 5
GY - Guiana 5
MU - Mauritius 5
PA - Panama 5
PR - Porto Rico 5
TH - Thailandia 5
AM - Armenia 4
BY - Bielorussia 4
GE - Georgia 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
MD - Moldavia 4
SN - Senegal 4
BB - Barbados 3
HT - Haiti 3
HU - Ungheria 3
KH - Cambogia 3
Totale 40.518
Città #
Fairfield 2.569
Ashburn 1.811
Singapore 1.522
Warsaw 1.470
Hong Kong 1.276
Woodbridge 1.210
Jacksonville 1.075
Seattle 970
Cambridge 926
Houston 905
Wilmington 835
San Jose 768
Council Bluffs 719
Dallas 624
Princeton 614
The Dalles 582
Chandler 564
Beijing 484
Ann Arbor 411
New York 365
Dublin 325
Lauterbourg 309
Istanbul 302
Los Angeles 275
Helsinki 235
Nanjing 235
Ho Chi Minh City 229
Des Moines 171
Moscow 150
Dearborn 136
Buffalo 133
Hanoi 131
Redondo Beach 131
Santa Clara 131
São Paulo 130
San Diego 128
Nürnberg 100
London 99
Chicago 94
Nanchang 89
Changsha 84
Columbus 78
Dong Ket 74
Phoenix 64
San Francisco 60
North Bergen 59
Milan 58
Brooklyn 57
Munich 56
Shanghai 56
Jinan 55
Orem 55
Rio de Janeiro 55
Rome 54
Hebei 53
Nuremberg 52
Jiaxing 51
Frankfurt am Main 46
Shenyang 46
Atlanta 41
Brasília 41
Brescia 41
Denver 40
Tianjin 38
Belo Horizonte 37
Montreal 37
Toronto 37
Curitiba 36
Boardman 35
Jakarta 31
Johannesburg 31
Naples 31
Brussels 30
Mexico City 30
San José 30
Hangzhou 29
Kunming 29
Orange 29
Poplar 29
Kocaeli 28
North York 28
Tokyo 28
Kilburn 26
Westminster 26
Bologna 25
Guangzhou 25
Dhaka 24
Guayaquil 24
Haiphong 24
Zhengzhou 24
Chennai 23
Lappeenranta 23
Romola 23
Tashkent 23
Fortaleza 22
Nairobi 22
Quito 22
Salt Lake City 22
Washington 22
Philadelphia 21
Totale 25.533
Nome #
1.5 T MR-guided and daily adapted SBRT for prostate cancer: Feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment 421
Weekly Cisplatin and Volumetric-Modulated Arc Therapy With Simultaneous Integrated Boost for Radical Treatment of Advanced Cervical Cancer in Elderly Patients: Feasibility and Clinical Preliminary Results 331
1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients 315
1.5 T MR-Guided Daily Adapted SBRT on Lymph Node Oligometastases from Prostate Cancer 281
Dose-volumerelated dysphagia after constrictor muscles definition in head and neck cancer intensitymodulated radiation treatment 274
Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: The point of view of the radiation oncologist 268
Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique 267
Dose variability in different lymph node levels during locoregional breast cancer irradiation: the impact of deep-inspiration breath hold 259
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: Role of local treatments 258
SBRT and extreme hypofractionation: A new era in prostate cancer treatments? 254
Postoperative breast radiotherapy after neoadjuvant chemotherapy: which uncertainties still remain? 247
Radiotherapy in patients with connective tissue diseases 241
Real-time intra-fraction motion management in breast cancer radiotherapy: Analysis of 2028 treatment sessions 241
Management of patients with cardiac implantable electronic devices (CIED) undergoing radiotherapy: A consensus document from Associazione Italiana Aritmologia e Cardiostimolazione (AIAC), Associazione Italiana Radioterapia Oncologica (AIRO), Associazione Italiana Fisica Medica (AIFM). 228
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 227
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 222
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 216
MR-guidance in clinical reality: Current treatment challenges and future perspectives 215
(Ga-68)-PSMA-PET/CT for the detection of postoperative prostate cancer recurrence: Possible implications on treatment volumes for radiation therapy 213
GUROPA survey: genito-urinary radiation oncology prescription attitudes 202
An update on radiation therapy in head and neck cancers 199
Mastectomy or breast-conserving therapy for early breast cancer in real-life clinical practice: outcome comparison of 7565 cases 198
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial 197
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 196
Radiotherapy in patients with HIV: current issues and review of the literature 195
Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study 194
ONE SHOT - single shot radiotherapy for localized prostate cancer: Study protocol of a single arm, multicenter phase I/II trial 191
Image-guided radiation therapy (IGRT): practical recommendations of Italian Association of Radiation Oncology (AIRO) 188
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective 185
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 184
Intra-fraction and Inter-fraction analysis of a dedicated immobilization device for intracranial radiation treatment 184
[11C]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 183
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 181
"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer? 176
Role of radiosurgery/stereotactic radiotherapy in oligometastatic disease: Brain oligometastases 173
Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system 171
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 171
A plethora of therapeutic opportunities for elderly patients with cancer: A nontrivial choice 170
11C choline PET guided salvage radiotherapy with volumetric modulation arc therapy and hypofractionation for recurrent prostate cancer after HIFU failure: preliminary results of tolerability and acute toxicity 169
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 169
Re: Giorgio Gandaglia, Alberto Briganti, Noel Clarke, et al. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.01.039. 167
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 166
18F-sodium fluoride PET-CT for the assessment of brain metastasis from lung Adenocarcinoma 165
What is changing in radiotherapy for the treatment of locally advanced nonsmall cell lung cancer patients? A review 162
Optical Surface Scanning for Patient Positioning in Radiation Therapy: A Prospective Analysis of 1902 Fractions 160
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis 158
Non-palliative radiotherapy in ab initio oligometastatic prostate cancer: an Italian national survey 157
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 156
Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer 156
Radiation dose-response relationship for risk of coronary heart disease in survivors of hodgkin lymphoma 156
Extreme hypofractionation for early prostate cancer: Biology meets technology 155
Interplay effects between dose distribution quality and positioning accuracy in total marrow irradiation with volumetric modulated arc therapy 154
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 153
Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer. 152
Stereotactic precision and conventional radiotherapy evaluation (SPACE)-Trial for medically inoperable Stage I NSCLC: A lost opportunity? 152
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 152
Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: Report of dosimetric and early clinical results in oligometastatic patients 151
Low-dose bath with volumetric modulated arc therapy in breast cancer: "much ado about nothing?" 150
Radiotherapy in the multidisciplinary treatment of liver cancer: a survey on behalf of the Italian Association of Radiation Oncology 148
Predictors of mucositis in oropharyngeal and oral cavity cancer in patients treated with volumetric modulated radiation treatment: A dose-volume analysis 146
Technical Note: Correction for intra-chamber dose gradients in reference dosimetry of flattening-filter-free MV photon beams 146
From radiobiology to technology: What is changing in radiotherapy for prostate cancer 146
Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study. 145
Choline-PET in prostate cancer management: The point of view of the radiation oncologist 145
Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature 145
Cancer Therapy combining high-intensity focused ultrasound and megavoltage radiation 145
Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature. 145
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 145
Current radiotherapy techniques in NSCLC: challenges and potential solutions 145
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies 143
Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: Dosimetric impact of an increased near-maximum target dose and of a rectal spacer 143
Prostate cancer as a paradigm of multidisciplinary approach? highlights from the italian young radiation oncologist meeting 142
Cone-beam computed tomography in lung stereotactic ablative radiation therapy: Predictive parameters of early response 142
Personalized - Not omitted - Radiation oncology for breast cancer 142
Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy 141
Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity 141
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists. 140
Organ sparing and clinical outcome with step-and-shoot IMRT for head and neck cancer: a mono-institutional experience 140
Neuroendocrine carcinoma of the breast: Current evidence and future perspectives 140
Watch-and-wait versus surgical resection for patients with rectal cancer 140
Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost 140
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 140
Stability and reproducibility of 6013 deep inspiration breath-holds in left-sided breast cancer 140
Toxicity of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: A potential comparison bias 139
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial. 139
Impact of weight loss in patients with head and neck carcinoma undergoing radiotherapy: Is it an underestimated phenomenon A radiation oncologist's perspective 139
Crowd knowledge based community in radiotherapy: In response to Yartev et al 138
Stereotactic radiosurgery for patients with brain metastases 137
Stereotactic radiosurgery for intracranial metastases: Linac-based and gamma-dedicated unit approach 137
[68Ga]Ga-PSMA Versus [18F]PSMA Positron Emission Tomography/Computed Tomography in the Staging of Primary and Recurrent Prostate Cancer. A Systematic Review of the Literature 136
Consolidative local therapy in oligometastatic patients 135
Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy 135
Spinal metastases: Is stereotactic body radiation therapy supported by evidences? 135
Three-dimensional conformal versus intensity modulated radiotherapy in breast cancer treatment: is necessary a medical reversal? 135
The impact of prostate gland dimension in genitourinary toxicity after definitive prostate cancer treatment with moderate hypofractionation and volumetric modulated arc radiation therapy 134
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani) 134
The BUONGIORNO project: Burnout syndrome among young italian radiation oncologists 134
Impact of surface-guided positioning on the use of portal imaging and initial set-up duration in breast cancer patients 134
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 134
Stereotactic body radiotherapy with flattening filter-free beams for prostate cancer: assessment of patient-reported quality of life 133
Totale 17.559
Categoria #
all - tutte 218.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 218.308


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.551 0 0 0 144 18 155 121 215 117 201 158 422
2022/20231.840 359 34 46 145 125 501 6 182 263 25 73 81
2023/20242.079 121 56 120 165 84 300 65 65 622 56 41 384
2024/20254.931 21 29 50 567 658 373 385 183 583 483 1.019 580
2025/202610.507 860 1.491 1.408 1.724 648 544 1.184 375 584 871 507 311
2026/20273.539 521 655 717 1.646 0 0 0 0 0 0 0 0
Totale 41.059